🕒 Thursday 10 July 2025 Thu, 10 July 2025

Whitefield Income Limited has announced fully franked monthly dividends of 0.583 cents per share for July through September 2025, delivering an 8.0% gross yield based on its IPO price.

Imagion Biosystems has received encouraging feedback from the FDA on its planned Phase 2 HER2 breast cancer clinical trial, paving the way for its Investigational New Drug application submission later this year.

Moab Minerals has raised $141,000 through a share placement and secured a $500,000 loan from European Lithium to fund exploration and working capital, underscoring strong shareholder support.

Ausgold Limited has raised A$35 million through a well-supported placement to accelerate its Katanning Gold Project in Western Australia towards a final investment decision.

Chariot Corporation Ltd has had its trading suspension lifted following an announcement about a proposed acquisition, signaling renewed market interest.

Chariot Corporation Ltd is set to acquire a 66.7% interest in a substantial Nigerian lithium portfolio, marking a strategic entry into Africa’s burgeoning lithium sector with a US$10 million funding commitment.

Turaco Gold’s latest drilling near the Woulo Woulo deposit reveals exceptional high-grade gold intercepts and expands mineralised zones at the Afema Project in Côte d’Ivoire.

Aguia Resources has scrapped its planned convertible note issue, converting $750,000 in subscriptions into a secured loan with a potential share conversion feature, pending shareholder approval.

Aguia Resources has locked in $2.687 million in loan commitments, including a $500,000 stake from its Executive Chairman, to fund ongoing mine development and exploration in Colombia. The loans feature convertible terms and options issuance, pending shareholder and ASX approvals.

Mindax Limited has raised $1.6 million through a discounted share placement to fund development and exploration activities at its Mt Forrest Iron Project and gold assets.

G50 Corp has confirmed a significant new precious metals discovery at its Golconda Project in Arizona, revealing extensive gold, silver, and zinc mineralization from its latest drilling program. The results also highlight notable gallium mineralization, underscoring the project's strategic value.

Victory Metals has significantly enhanced its North Stanmore resource with Gallium inclusion and secured major financing commitments exceeding US$200 million, positioning itself as a strategic supplier amid global rare earths tensions.

Neurizon Therapeutics has received positive feedback from the FDA on its plan to resolve the clinical hold on its ALS drug candidate NUZ-001, with key preclinical studies completed ahead of schedule. The company aims to resume clinical trials in late 2025.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

Australian Rare Earths Limited (ASX, AR3) has acquired exploration license EL6895, adding 972 km² to its Overland Uranium Project and uncovering significant near-surface uranium potential from historic data. Drilling is set to resume in July 2025 to test this promising new target alongside existing deeper uranium prospects.

Osmond Resources has significantly expanded its Orion EU Critical Minerals Project by 160%, with promising assay results and a planned drilling program to confirm mineral continuity. The company is positioning itself to benefit from strong EU demand for rare earths, titanium, and silicon metals.

Pacgold has identified a compelling IP chargeability anomaly coincident with a magnetic bullseye at its White Lion Prospect, echoing signatures seen at the Mt Leyshon gold deposit. Drilling is planned for Q4 2025 following heritage clearances.

Race Oncology has secured key ethics approvals to launch its Phase 1 RC220 trial at two major Hong Kong hospitals, marking a strategic expansion beyond Australia to accelerate patient recruitment and explore cardioprotective benefits.

American West Metals reports promising visual copper mineralisation from deep drilling and identifies multiple new targets via advanced geophysics at its Storm Copper Project in Nunavut, Canada.

Kinterra Infrastructure has increased its takeover offer for New World Resources shares to A$0.063, with a potential rise to A$0.064 if it secures over 30% ownership. This move intensifies the takeover battle against rival CAML, promising quicker payments and stronger funding assurances.

Spectur Ltd reports a stronger cash position driven by operational improvements and strategic cloud investments, while FY25 revenue slightly misses guidance due to delayed orders.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

Change Financial has surpassed its FY25 revenue targets and is set to report its first positive underlying EBITDA, signaling a pivotal shift for the fintech. The company also projects strong revenue and earnings growth for FY26, underpinned by robust sales momentum and operational efficiencies.

Artrya Limited has secured a five-year, US$0.6 million contract with Tanner Health, marking its inaugural commercial revenue in the U.S. market for its AI-powered Salix Coronary Anatomy platform.